206 related articles for article (PubMed ID: 29914943)
1. Population Pharmacokinetics and Cerebrospinal Fluid Penetration of Fluconazole in Adults with Cryptococcal Meningitis.
Stott KE; Beardsley J; Kolamunnage-Dona R; Castelazo AS; Kibengo FM; Mai NTH; Tùng NLN; Cuc NTK; Day J; Hope W
Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 29914943
[TBL] [Abstract][Full Text] [Related]
2. Population Pharmacokinetic Model and Meta-analysis of Outcomes of Amphotericin B Deoxycholate Use in Adults with Cryptococcal Meningitis.
Stott KE; Beardsley J; Whalley S; Kibengo FM; Mai NTH; Tùng NLN; Cuc NTK; Kolamunnage-Dona R; Hope W; Day J
Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29735567
[TBL] [Abstract][Full Text] [Related]
3. Fluconazole Monotherapy Is a Suboptimal Option for Initial Treatment of Cryptococcal Meningitis Because of Emergence of Resistance.
Hope W; Stone NRH; Johnson A; McEntee L; Farrington N; Santoro-Castelazo A; Liu X; Lucaci A; Hughes M; Oliver JD; Giamberardino C; Mfinanga S; Harrison TS; Perfect JR; Bicanic T
mBio; 2019 Dec; 10(6):. PubMed ID: 31796539
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and pharmacodynamics of fluconazole for cryptococcal meningoencephalitis: implications for antifungal therapy and in vitro susceptibility breakpoints.
Sudan A; Livermore J; Howard SJ; Al-Nakeeb Z; Sharp A; Goodwin J; Gregson L; Warn PA; Felton TW; Perfect JR; Harrison TS; Hope WW
Antimicrob Agents Chemother; 2013 Jun; 57(6):2793-800. PubMed ID: 23571544
[TBL] [Abstract][Full Text] [Related]
5. Relationship between intracranial pressure and antifungal agents levels in the CSF of patients with cryptococcal meningitis.
Wirth F; de Azevedo MI; Pilla C; Aquino VR; Neto GW; Goldani LZ
Med Mycol; 2018 Apr; 56(3):257-262. PubMed ID: 28992308
[TBL] [Abstract][Full Text] [Related]
6. Antifungal susceptibilities of Cryptococcus neoformans cerebrospinal fluid isolates and clinical outcomes of cryptococcal meningitis in HIV-infected patients with/without fluconazole prophylaxis.
Manosuthi W; Sungkanuparph S; Thongyen S; Chumpathat N; Eampokalap B; Thawornwan U; Foongladda S
J Med Assoc Thai; 2006 Jun; 89(6):795-802. PubMed ID: 16850679
[TBL] [Abstract][Full Text] [Related]
7. Fluconazole plus flucytosine is a good alternative therapy for non-HIV and non-transplant-associated cryptococcal meningitis: A retrospective cohort study.
Li Z; Liu Y; Chong Y; Li X; Jie Y; Zheng X; Yan Y
Mycoses; 2019 Aug; 62(8):686-691. PubMed ID: 31120606
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics-pharmacodynamics of sertraline as an antifungal in HIV-infected Ugandans with cryptococcal meningitis.
Alhadab AA; Rhein J; Tugume L; Musubire A; Williams DA; Abassi M; Nicol MR; Meya DB; Boulware DR; Brundage RC;
J Pharmacokinet Pharmacodyn; 2019 Dec; 46(6):565-576. PubMed ID: 31584146
[TBL] [Abstract][Full Text] [Related]
9. Cryptococcosis in pregnancy and the postpartum period: Case series and systematic review with recommendations for management.
Pastick KA; Nalintya E; Tugume L; Ssebambulidde K; Stephens N; Evans EE; Ndyetukira JF; Nuwagira E; Skipper C; Muzoora C; Meya DB; Rhein J; Boulware DR; Rajasingham R
Med Mycol; 2020 Apr; 58(3):282-292. PubMed ID: 31689712
[TBL] [Abstract][Full Text] [Related]
10. Monitoring and impact of fluconazole serum and cerebrospinal fluid concentration in HIV-associated cryptococcal meningitis-infected patients.
Manosuthi W; Chetchotisakd P; Nolen TL; Wallace D; Sungkanuparph S; Anekthananon T; Supparatpinyo K; Pappas PG; Larsen RA; Filler SG; Andes D;
HIV Med; 2010 Apr; 11(4):276-81. PubMed ID: 20002501
[TBL] [Abstract][Full Text] [Related]
11. Factors associated with early mycological clearance in HIV-associated cryptococcal meningitis.
Concha-Velasco F; González-Lagos E; Seas C; Bustamante B
PLoS One; 2017; 12(3):e0174459. PubMed ID: 28355252
[TBL] [Abstract][Full Text] [Related]
12. Short-course amphotericin B in addition to sertraline and fluconazole for treatment of HIV-associated cryptococcal meningitis in rural Tanzania.
Katende A; Mbwanji G; Faini D; Nyuri A; Kalinjuma AV; Mnzava D; Hullsiek KH; Rhein J; Weisser M; Meya DB; Boulware DR; Letang E;
Mycoses; 2019 Dec; 62(12):1127-1132. PubMed ID: 31461550
[TBL] [Abstract][Full Text] [Related]
13. Increased Antifungal Drug Resistance in Clinical Isolates of Cryptococcus neoformans in Uganda.
Smith KD; Achan B; Hullsiek KH; McDonald TR; Okagaki LH; Alhadab AA; Akampurira A; Rhein JR; Meya DB; Boulware DR; Nielsen K;
Antimicrob Agents Chemother; 2015 Dec; 59(12):7197-204. PubMed ID: 26324276
[TBL] [Abstract][Full Text] [Related]
14. Treatment of acute cryptococcal meningitis in HIV infected adults, with an emphasis on resource-limited settings.
Sloan D; Dlamini S; Paul N; Dedicoat M
Cochrane Database Syst Rev; 2008 Oct; (4):CD005647. PubMed ID: 18843697
[TBL] [Abstract][Full Text] [Related]
15. Triple therapy combined with ventriculoperitoneal shunts can improve neurological function and shorten hospitalization time in non-HIV cryptococcal meningitis patients with increased intracranial pressure.
Li M; Liu J; Deng X; Gan Q; Wang Y; Xu X; Jiang Y; Peng F
BMC Infect Dis; 2020 Nov; 20(1):844. PubMed ID: 33198666
[TBL] [Abstract][Full Text] [Related]
16. An open label randomized controlled trial of tamoxifen combined with amphotericin B and fluconazole for cryptococcal meningitis.
Ngan NTT; Thanh Hoang Le N; Vi Vi NN; Van NTT; Mai NTH; Van Anh D; Trieu PH; Lan NPH; Phu NH; Chau NVV; Lalloo DG; Hope W; Beardsley J; White NJ; Geskus R; Thwaites GE; Krysan D; Tai LTH; Kestelyn E; Binh TQ; Hung LQ; Tung NLN; Day JN
Elife; 2021 Sep; 10():. PubMed ID: 34581270
[TBL] [Abstract][Full Text] [Related]
17. Experimental Models of Short Courses of Liposomal Amphotericin B for Induction Therapy for Cryptococcal Meningitis.
Lestner J; McEntee L; Johnson A; Livermore J; Whalley S; Schwartz J; Perfect JR; Harrison T; Hope W
Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28320715
[TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo efficacies of the azole SCH56592 against Cryptococcus neoformans.
Perfect JR; Cox GM; Dodge RK; Schell WA
Antimicrob Agents Chemother; 1996 Aug; 40(8):1910-3. PubMed ID: 8843302
[TBL] [Abstract][Full Text] [Related]
19. Dose response effect of high-dose fluconazole for HIV-associated cryptococcal meningitis in southwestern Uganda.
Longley N; Muzoora C; Taseera K; Mwesigye J; Rwebembera J; Chakera A; Wall E; Andia I; Jaffar S; Harrison TS
Clin Infect Dis; 2008 Dec; 47(12):1556-61. PubMed ID: 18990067
[TBL] [Abstract][Full Text] [Related]
20. Fluconazole and amphotericin B for cryptococcal meningitis.
Clark AB; Lobo BL; Gelfand MS
Ann Pharmacother; 1996 Dec; 30(12):1408-10. PubMed ID: 8968453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
